Americana Partners, LLC Repligen Corp Transaction History

Americana Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$170.78 - $208.42 $17,078 - $20,842	-100 Reduced 6.79%	1,372 $252,000
Q4 2023 Jan 25, 2024	SELL	$114.17 - $185.35 $1.59 Million - $2.59 Million	-13,958 Reduced 90.46%	1,472 $264,000
Q3 2023 Nov 07, 2023	BUY	$138.78 - $176.51 $20,400 - $25,946	147 Added 0.96%	15,430 $2.45 Million
Q2 2023 Jul 31, 2023	SELL	$138.42 - $180.31 $839,794 - $1.09 Million	-6,067 Reduced 28.42%	15,283 $2.16 Million
Q1 2023 May 08, 2023	SELL	$154.26 - $198.1 $19,282 - $24,762	-125 Reduced 0.58%	21,350 $3.59 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $2.69 Million - $3.6 Million	19,125 Added 813.83%	21,475 $3.49 Million
Q1 2022 May 06, 2022	SELL	$161.19 - $257.96 $3.14 Million - $5.02 Million	-19,470 Reduced 89.23%	2,350 $442,000
Q4 2021 Jan 28, 2022	BUY	$247.59 - $304.47 $2.51 Million - $3.09 Million	10,139 Added 86.8%	21,820 $5.78 Million
Q3 2021 Nov 08, 2021	BUY	$194.77 - $324.21 $2.28 Million - $3.79 Million	11,681 New	11,681 $3.38 Million

496

53.9M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.72B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Americana Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Americana Partners, LLC with notifications on news.